Home > Cancer Institute > Surgical Oncology > Clinical Conditions & Program Offerings > Peritoneal Surface Malignancy

Surgical Oncology:
Clinical Conditions & Program Offerings

Peritoneal Surface Malignancy

The peritoneum is the membrane that lines the cavity of the abdomen. Peritoneal surface malignancy refers to a wide variety of tumors that include extensive peritoneal involvement and may or may not also involve solid organs such as the liver, spleen and lymph nodes. These tumors originate from the appendix, colon, rectum, stomach, ovaries and other organs and then spread by crawling on the peritoneal surface of the abdominal cavity and other organs. It can also originate in the peritoneal lining and are called mesotheliomas or primary peritoneal cancers. Commonly thought of as incurable tumors in the past, they respond well to an aggressive therapy consisting of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Dr. Sardi and his clinical team are recognized nationally as leaders in aggressive cytoreductive surgery utilized in conjunction with hyperthermic intraperitoneal chemotherapy (HIPEC). It is effective for patients with peritoneal carcinomatosis of the colon, rectum, stomach, appendix, and ovaries as well as mesotheliomas, sarcomas and primary peritoneal cancers. Due to the complexity of the combined therapy of cytoreductive surgery and HIPEC, only a handful of surgeons are appropriately trained and experienced to offer this treatment method.  Our surgical oncology team performs this procedure on a regular basis and offers a high level of expertise along with a specialized clinical team to patients facing a diagnosis of peritoneal cancer.

In collaboration with the National Institutes of Health (NIH) and other scientific groups we also conduct many clinical and translational studies to perfect this treatment approach.

For more information on HIPEC treatment see screening and qualifications, Mercy’s HIPEC booklet, and HIPEC definitions.

See Dr. Sardi discussing HIPEC treatment:

• In an ABC 2 News story.
• On Denver News 7.

Other clinical conditions managed by Surgical Oncology at Mercy:

• Tumors of the digestive system and gastrointestinal tract
  
• Liver tumors
  
• Pancreatic tumors
  
• Melanoma and other skin-related malignancies
  
• Sarcomas
  
• Endocrine disorders including thyroid and parathyroid disease
  
• Peritoneal surface malignancies

Now Accepting New Patients.
Most Insurances Accepted.

Please call for an appointment.
Phone: 410-332-9294
Tollfree: 1-800-MD-Mercy (1-800-636-3729)